OWN YOUR BODY
SIGNOS IS ALL ABOUT YOU.
Launched in 2018, Signos, Inc. is on a mission to eliminate obesity by igniting the metabolic health movement. The company's mobile AI-driven app, powered by a continuous glucose monitor (CGM), offers personalized insights into how food, movement, sleep, stress, and more affect each unique body enabling people to seize their health.
With over 73% of Americans overweight or obese, Signos offers a science-backed path to sustainable weight management through the lens of individual metabolism. Founded by experts in data science, AI, and behavioral design, the company is committed to building technology that drives better health outcomes.
DOWNLOAD THE FULL KIT
OUR MISSION
At Signos, we envision a world where people are no longer passive passengers in their health journey; rather, they are powerful, informed decision-makers. Currently, we are overwhelmed by noise, misinformation, and profit-driven health advice. Signos exists to cut through the chaos. Our mission is to revolutionize the way individuals understand and respond to their bodies in real time, transforming metabolic health from reactive to proactive. We challenge the old rules, rewrite the narrative, and empower people to reclaim control of their health — one data point, one breakthrough, one life at a time.
KEY HIGHLIGHTS
- Headquartered in Palo Alto, CA
- Founded in 2018
- Led by Sharam Fouladgar-Mercer, CEO
- Available on iOS and Android
BRAND COLORS
LOGOS
Our logo is comprised of the Signos symbol paired with the Signos wordmark, set in uppercase. Our primary logo is the symbol locked up with the wordmark.
Symbol
The Signos symbol is a stylized “s-shape” that we call the Zag. It is a bold and dynamic shape and paired with a bright pink we call Cerise. It is a symbol of our defiance and action.
Wordmark
The letterforms are thin by comparison, and slightly rounded to pick up cues from the curvilinear shape of the zag. Uppercase helps the logo feel trustworthy and while the rounded shapes and humanist letterforms make the logo approachable.
Stacked Logo
Use for square or limited horizontal footprints where it is critical to still see the Signos wordmark (ie marketplaces)
Symbol
Use for avatars and instances in assets after the primary logo has been established.
Wordmark
Use for instances in assets after the primary logo has been established or when a more sophisticated or subtle approach is more appropriate.
TYPOGRAPHY
Archivo
Our primary font is Archivo – a strong geometric sans serif typeface that when set in upper case is often associated with newspaper headlines and activist posters due to it’s readability, boldness and the economy of the letterforms. Archivo carries those associations of urgency and defiance that is part of the Signos ethos.
Archivo is variable font and as such provide a range of type flexibility. All styles are available for use, however there are 3 we use more commonly in brand communication – Extra Condensed and Expanded for headlines and Standard for body copy.
Archivo is licensed by Google Fonts and is available at
https://fonts.google.com/specimen/Archivo
Jet Brains Mono
Our accent font is Jet Brains Mono. Jet Brains is designed to display computer code due to its simple letterforms and readability at small sizes. Using Jet Brains creates associations to data and intelligence and compliments the more activist Archivo family.
Monospaced fonts are not designed to be read in long story form. As such, we use Jet Brains only for captions, modifiers, and labels.
Jet Brains Mono is licensed by Google Fonts and is available at
https://fonts.google.com/specimen/JetBrains+Mono
IN THE NEWS
SIGNOS INDICATIONS: The Signos Glucose Monitoring System is an over-the-counter (OTC) mobile device application that receives data from an integrated Continuous Glucose Monitor (iCGM) sensor and is intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Signos Glucose Monitoring System helps to detect normal (euglycemic) and low or high (dysglycemic) glucose levels. The Signos Glucose Monitoring System may also help the user better understand how lifestyle and behavior modification, including diet and exercise, impact glucose excursions. This information may be useful in helping users to maintain a healthy weight.
The user is not intended to take medical action based on the device output without consultation with a qualified healthcare professional.
See user guide for important warnings and precautions.
STELO IMPORTANT INFORMATION: Consult your healthcare provider before making any medication adjustments based on your sensor readings and do not take any other medical action based on your sensor readings without consulting your healthcare provider. Do not use if you have problematic hypoglycemia. Failure to use Stelo and its components according to the instructions for use provided and to properly consider all indications, contraindications, warnings, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence. If your sensor readings are not consistent with your symptoms, a blood glucose meter may be an option as needed and consult your healthcare provider. Seek medical advice and attention when appropriate, including before making any medication adjustments and/or for any medical emergency.
STELO INDICATIONS FOR USE: The Stelo Glucose Biosensor System is an over-the-counter (OTC) integrated Continuous Glucose Monitor (iCGM) intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Stelo Glucose Biosensor System helps to detect normal (euglycemic) and low or high (dysglycemic) glucose levels. The Stelo Glucose Biosensor System may also help the user better understand how lifestyle and behavior modification, including diet and exercise, impact glucose excursion. The user is not intended to take medical action based on the device output without consultation with a qualified healthcare professional.
